Yes, I have. I welcome the fact that the Government has undertaken a fresh consultation. Members will remember that we thought that we had solved this problem during the previous parliamentary session, but clearly we have not. There is considerable anxiety among remote and rural practices about the development of pharmacy. The committee will appreciate that we are therefore faced with the dichotomy of wanting to provide good and full pharmacy services to communities on the one hand and, on the other, wanting not to disrupt or in any way to reduce the general medical services that are being offered by GPs.
The new regulations have been lodged and will be considered by the Health and Sport Committee at its meeting next week. I do not propose to seek to annul the instrument because the regulations are a considerable advance on what we have had until now. However, there are some questions that I want to raise for the committee’s information as much as anything, so I invite the committee to consider keeping the petition open a little longer to see what the minister’s response is next week.
First, there is the new concept of protecting rural and remote practices by designating them as practices where there should not be a pharmacy. That is new and it is very welcome. However, there is not a very clear definition of that concept, and the status of the practices concerned is to be reviewed every three years.
I declare an interest as a fellow of the Royal College of General Practitioners and a member of the British Medical Association. Frankly, when you are running a business, which is what GPs are doing, a three-year review is not adequate. You need certainty over a longer period, so I am slightly concerned about the three-year review, as well as about the vagueness of the definition. The regulations say that the practices will be designated as protected, but we do not know what the definition of that status is.
I also have some concerns about the consultation process, which is now to be agreed between the applicant and the board. There does not appear to be any role for either the GP or the community in agreeing the consultation process. Moreover, there is no external agency looking at this, as there is with the rest of the health service through the Scottish health council. There is something lacking when it comes to ensuring that consultation follows a process. We have no idea what the process is, because it is not defined in the regulations.
There is no requirement on the practice and the health board jointly to agree specifically any changes to services that might occur following loss of dispensing. Members will know that Millport is the worst example—the GPs there have all resigned. It is costing us as taxpayers and it is costing the Government and the health board a huge amount of money to provide locums, because the board cannot get GPs. There has also been a reduced service in Leuchars. In Methven, in my constituency, the GMS was previously a full-day service and is now a half-day service, so patients have to travel from Methven to Perth. None of that came out in the licensing process.
Three other practices in my area also have issues: Aberfoyle, Killin and Drymen. In Drymen, the GPs have both resigned as of 31 July. In Killin, there are particular problems, which I will not go into, but it looks like a diminished number of GPs will be present. In Aberfoyle, an appeal has just been upheld despite the fact that in the initial consideration by the local pharmacy board—the appropriate board—the pharmacy was regarded as being potentially unsustainable, which is one of the criteria under the new regulations.
There is also the question whether there should in the future be redress for practices that are affected by licensing. That has not been the practice in the past, and I would not argue for GPs to be in a position to sell goodwill. They never have been and they never should be. Their dispensing rights are given to them by the board and they are required to dispense by the board—they should not have the right to sell that goodwill. Nevertheless, GPs make an investment. I will give the committee another example. About two years ago, the Drymen practice invested £3,500 or £4,000 in software to improve the safety of its dispensing. However, it gets no recompense for that for losing its licence and the requirement to dispense. There should at least be an assessment of the effect on the practice of the loss of dispensing, in terms of both its software and the premises.
Are there arrangements for redundancy of dispensing staff? Are there Transfer of Undertakings (Protection of Employment) Regulations arrangements? That again does not come up under the regulations.
Finally, nothing in the new regulations promotes co-location of GPs and pharmacists. Indeed, I understand that pharmacists locally can currently object to co-location on the basis that it would give someone an unfair advantage and therefore it may not occur.
I am sorry to go on at length, convener—I know that the committee has a long agenda—but we are having yet another shot at this, so we need to get it right. I wonder whether the committee would consider keeping the petition open at least until the minister has answered the questions, which the minister now has notice of as a result of your having courteously allowed me to speak to the committee.
